Dipenkumar Modi
Barbara Ann Karmanos Cancer Institute · Barbara Ann Karmanos Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dipenkumar Modi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:14 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05222438 · Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post TransplantBarbara Ann Karmanos Cancer Institute · withdrawn · Relapsed Diffuse Large B-cell Lymphoma · principal investigator
- Ph2NCT04479267 · Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated LymphomaBarbara Ann Karmanos Cancer Institute · active not recruiting · Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6 Rearrangements · principal investigator
- Ph1NCT04234048 · Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaSciTech Development, Inc. · recruiting · T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma · principal investigator
- Ph1/Ph2NCT03147885 · Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin LymphomaBarbara Ann Karmanos Cancer Institute · active not recruiting · Diffuse Large B-Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma · principal investigator
- Ph2NCT02824029 · Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin LymphomaBarbara Ann Karmanos Cancer Institute · completed · Classical Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Research Training and Education CoordinationP30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Morhaf Al Achkar · fiscal years 1997 to 2026
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:14 UTC. The ranking covers the 200 most relevant of 23 PubMed records, and a shared surname and initials can bring in a namesake. All 23 on PubMed
- First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors.Clin Cancer Res · 2019134 citationsRCR 4.4
- Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial.Nat Med · 2024103 citationsRCR 11.4
- 85 citationsRCR 6.8
- 66 citationsRCR 12.5
- 60 citationsRCR 3.0
- Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.J Clin Oncol · 202541 citationsRCR 11.6
- Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.Invest New Drugs · 202225 citationsRCR 1.7
- Costing and Cost-Effectiveness of a Mobile Health Intervention (ImTeCHO) in Improving Infant Mortality in Tribal Areas of Gujarat, India: Cluster Randomized Controlled Trial.JMIR Mhealth Uhealth · 202022 citationsRCR 1.9
- 18 citationsRCR 1.1
- High uptake of an innovative mobile phone application among community health workers in rural India: An implementation study.Natl Med J India · 201913 citationsRCR 1.1